116 related articles for article (PubMed ID: 9882697)
1. Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes.
Ma D; Wu P; Egan RW; Billah MM; Wang P
Mol Pharmacol; 1999 Jan; 55(1):50-7. PubMed ID: 9882697
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils.
Wang P; Wu P; Ohleth KM; Egan RW; Billah MM
Mol Pharmacol; 1999 Jul; 56(1):170-4. PubMed ID: 10385698
[TBL] [Abstract][Full Text] [Related]
3. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
Verghese MW; McConnell RT; Lenhard JM; Hamacher L; Jin SL
Mol Pharmacol; 1995 Jun; 47(6):1164-71. PubMed ID: 7603456
[TBL] [Abstract][Full Text] [Related]
4. Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses.
Jin SL; Conti M
Proc Natl Acad Sci U S A; 2002 May; 99(11):7628-33. PubMed ID: 12032334
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages.
Yang JX; Hsieh KC; Chen YL; Lee CK; Conti M; Chuang TH; Wu CP; Jin SC
Sci Rep; 2017 Apr; 7():46165. PubMed ID: 28383060
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
Seldon PM; Barnes PJ; Giembycz MA
Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
[TBL] [Abstract][Full Text] [Related]
7. Enhanced PDE4B expression augments LPS-inducible TNF expression in ethanol-primed monocytes: relevance to alcoholic liver disease.
Gobejishvili L; Barve S; Joshi-Barve S; McClain C
Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G718-24. PubMed ID: 18687753
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by interleukin-10 of inducible cyclooxygenase expression in lipopolysaccharide-stimulated monocytes: its underlying mechanism in comparison with interleukin-4.
Niiro H; Otsuka T; Tanabe T; Hara S; Kuga S; Nemoto Y; Tanaka Y; Nakashima H; Kitajima S; Abe M
Blood; 1995 Jun; 85(12):3736-45. PubMed ID: 7780157
[TBL] [Abstract][Full Text] [Related]
9. Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages.
Jin SL; Lan L; Zoudilova M; Conti M
J Immunol; 2005 Aug; 175(3):1523-31. PubMed ID: 16034090
[TBL] [Abstract][Full Text] [Related]
10. Ferulic acid prevents LPS-induced up-regulation of PDE4B and stimulates the cAMP/CREB signaling pathway in PC12 cells.
Huang H; Hong Q; Tan HL; Xiao CR; Gao Y
Acta Pharmacol Sin; 2016 Dec; 37(12):1543-1554. PubMed ID: 27665850
[TBL] [Abstract][Full Text] [Related]
11. Suppression of tumor necrosis factor alpha production by cAMP in human monocytes: dissociation with mRNA level and independent of interleukin-10.
Shames BD; McIntyre RC; Bensard DD; Pulido EJ; Selzman CH; Reznikov LL; Harken AH; Meng X
J Surg Res; 2001 Aug; 99(2):187-93. PubMed ID: 11469886
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cAMP-specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons.
D'Sa C; Tolbert LM; Conti M; Duman RS
J Neurochem; 2002 May; 81(4):745-57. PubMed ID: 12065634
[TBL] [Abstract][Full Text] [Related]
13. Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B.
Manning CD; Burman M; Christensen SB; Cieslinski LB; Essayan DM; Grous M; Torphy TJ; Barnette MS
Br J Pharmacol; 1999 Dec; 128(7):1393-8. PubMed ID: 10602317
[TBL] [Abstract][Full Text] [Related]
14. Differential expression and function of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells: predominant role of PDE4D.
Peter D; Jin SL; Conti M; Hatzelmann A; Zitt C
J Immunol; 2007 Apr; 178(8):4820-31. PubMed ID: 17404263
[TBL] [Abstract][Full Text] [Related]
15. Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B.
Manning CD; McLaughlin MM; Livi GP; Cieslinski LB; Torphy TJ; Barnette MS
J Pharmacol Exp Ther; 1996 Feb; 276(2):810-8. PubMed ID: 8632354
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs.
Hinz B; Brune K; Pahl A
Biochem Biophys Res Commun; 2000 Nov; 278(3):790-6. PubMed ID: 11095985
[TBL] [Abstract][Full Text] [Related]
17. Effects of PDE4 inhibitors on lipopolysaccharide-induced priming of superoxide anion production from human mononuclear cells.
Germain N; Corbel M; Belleguic C; Boichot E; Lagente V
Mediators Inflamm; 2001 Jun; 10(3):117-23. PubMed ID: 11545248
[TBL] [Abstract][Full Text] [Related]
18. Expression and regulation of mRNA for distinct isoforms of cAMP-specific PDE-4 in mitogen-stimulated and leukemic human lymphocytes.
Jiang X; Paskind M; Weltzien R; Epstein PM
Cell Biochem Biophys; 1998; 28(2-3):135-60. PubMed ID: 9515164
[TBL] [Abstract][Full Text] [Related]
19. Suppression of granulocyte/macrophage colony-stimulating factor release from human monocytes by cyclic AMP-elevating drugs: role of interleukin-10.
Seldon PM; Giembycz MA
Br J Pharmacol; 2001 Sep; 134(1):58-67. PubMed ID: 11522597
[TBL] [Abstract][Full Text] [Related]
20. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.
Foey AD; Field S; Ahmed S; Jain A; Feldmann M; Brennan FM; Williams R
Arthritis Res Ther; 2003; 5(6):R317-28. PubMed ID: 14680506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
